Core Insights - The latest data from the Hong Kong Stock Exchange indicates that on August 18, shareholders of Deking Pharmaceutical-B (06996) deposited shares worth HKD 416 million into Standard Chartered Bank (Hong Kong), representing 9.23% of the total shareholding [1] - On July 28, Deking Pharmaceutical announced that the National Medical Products Administration (NMPA) of China has approved the use of Xivio (Selinexor) in combination with Bortezomib and Dexamethasone (XVd) for the treatment of adult patients with relapsed or refractory multiple myeloma (MM) who have received at least one prior therapy, marking a new indication for Xivio [1]

Core Viewpoint - The company, Gilead Sciences, announced a placement and subscription agreement for the sale of 52,400,000 shares at a price of HKD 16.45 per share, representing a discount of approximately 9.9% from the last closing price of HKD 18.26 on August 18 [1] Group 1 - The net proceeds from the subscription are expected to be approximately HKD 467.69 million after deducting commissions and estimated expenses [1] - Approximately 90% of the net proceeds is intended for the clinical trial development of subcutaneous and oral peptide candidates related to obesity [1] - About 10% of the net proceeds is suggested to be used for working capital and other general corporate purposes [1]

来源：智通财经APP 特朗普政府正探讨通过《芯片与科学法案》资金收购英特尔(INTC.US)约10%股权的方案，此举或使美 国政府成为这家陷入困境的芯片制造商的最大股东。据白宫官员及知情人士透露，联邦政府考虑将原本 分期拨付的《芯片法案》资金转换为股权投资，涉及金额可能涵盖英特尔已获批的109亿美元商业与军 事生产补贴。然而，正当特朗普政府盘算着入股英特尔，日本软银已抢先落子——20亿美元投资协议已 尘埃落定。 以当前市值计算，10%股权对应价值约105亿美元，与英特尔已获得的22亿美元首期拨款存在部分重 叠，具体操作细节及时间表尚未明确。白宫发言人库什·德赛拒绝就谈判细节置评，仅强调"任何协议在 正式宣布前均非最终定论"。负责监管《芯片法案》的美国商务部同样未发表评论，英特尔方面也未回 应置评请求。 这一思路与五角大楼上月宣布收购MP Materials稀土公司15%优先股的举措形成呼应，凸显华盛顿在关 键产业链上的资本布局倾向。 值得一提的是，在特朗普政府探讨投资英特尔之际，日本软银集团已达成协议向这家美国芯片制造商注 资20亿美元。根据最终证券购买协议条款，软银将以每股23美元的价格直接购入英特尔普通股 ...

Core Viewpoint - The company, Harbin Electric Group Jiamusi Electric Machine Co., Ltd., has approved a proposal to increase capital for its wholly-owned subsidiary, Jiamusi Electric Machine Co., Ltd., to implement fundraising projects, aiming to diversify its business structure and enhance resilience against market fluctuations [1]. Group 1: Company Actions - The company held its 37th meeting of the 9th Board of Directors and the 30th meeting of the 9th Supervisory Board on March 27, 2025, where the capital increase proposal was approved [1]. - The subsidiary, Jiamusi Electric Machine Co., Ltd., has completed the necessary business registration changes and received a new business license from the Jiamusi Market Supervision Administration [1]. Group 2: Business Scope Expansion - The subsidiary plans to expand its business scope to include manufacturing and sales of communication equipment, instruments, IoT devices, information system integration services, industrial internet data services, and sales of mechanical parts [1][3]. - The updated business scope also includes general projects such as electric motor manufacturing, electrical equipment sales, and various technical services [3]. Group 3: Company Information - The registered capital of Jiamusi Electric Machine Co., Ltd. is 12.193981 billion yuan, and it was established on June 23, 2000 [2]. - The company operates under the jurisdiction of Jiamusi City, Heilongjiang Province, with multiple business locations [2].

Group 1: Google and Nuclear Energy - Google announced a partnership with Kairos Power and TVA to deploy an advanced nuclear power plant by 2030, marking TVA as the first U.S. utility to purchase power from a GEN IV reactor [1] - The Hermes 2 nuclear plant in Oak Ridge, Tennessee, will supply TVA with up to 50 megawatts of reliable power, supporting Google's data centers in Tennessee and Alabama [1] Group 2: U.S. Government and Intel - The Trump administration is reportedly in talks to acquire approximately 10% of Intel, potentially making the U.S. federal government the largest shareholder of the chip manufacturer [2] - This move reflects the U.S. government's strategic intent to gain control over the semiconductor industry, which could reshape Intel's competitive position [2] Group 3: Novo Nordisk and Ozempic Pricing - Novo Nordisk announced a significant price reduction for its diabetes drug Ozempic in the U.S., with cash-paying patients now able to purchase it for $499 per month, down from nearly $1,350 [3] - This price cut aims to lower medication costs for patients and increase drug accessibility, potentially impacting the pricing strategies of similar diabetes medications [3] Group 4: OpenAI and AI Market - OpenAI CEO Sam Altman acknowledged that the AI market is entering a bubble phase, driven by exaggerated trends [4] - Altman also indicated that OpenAI plans to invest tens of billions of dollars in data center expansion in the near future, highlighting the company's ambition in AI infrastructure [4] Group 5: Google and TeraWulf - TeraWulf's stock surged over 19% following Google's announcement of increasing its stake in the company from 8% to 14%, providing $14 billion in incremental guarantees [5] - This strategic move by Google aims to bolster its data center resources to support AI and cloud computing needs while instilling confidence and funding for TeraWulf's growth [5]

8月19日，据报道，特朗普政府正在讨论持有英特尔约10%的股份。美政府正在考虑对英特尔进行潜在 投资，该投资涉及将英特尔根据《芯片与科学法案》获得的部分或全部拨款转换为股权。英特尔预计将 获得总计109亿美元的芯片法案拨款，用于商业和军事生产。以英特尔目前的市值计算，这家芯片制造 商10%的股份价值约为105亿美元。 ...

翰 森制药 视觉中国 资料图 在创新药收入的正向影响下，翰森制药上半年交出了收入和净利润双位数增长的成绩单。 8月18日晚间，翰森制药（3692.HK）发布2025年半年报，上半年收入约74.34亿元，同比增长约 14.3%。其中，创新药与合作产品销售收入约61.45亿元，同比增长约22.1%，占总收入的约82.7%。此 外，公司上半年溢利约31.35亿元，同比增长约15%；每股基本盈利约0.53元，同比增长约14.8%。 翰森制药称，上半年收入、溢利及每股基本盈利的增加主要是由于创新药与合作产品销售收入的增长。 | | | 截至6月30日止六個月 | | | --- | --- | --- | --- | | | 附註 | 2025年 | 2024年 | | | | (未經審核) | (未經審核) | | | | 人民幣千元 | 人民幣千元 | | 收入 | 4 | 7,433,559 | 6,505,501 | | 销售成本 | | (660,786) | (579,218) | | 毛利 | | 6,772,773 | 5,926,283 | | 其他收入 | 4 | 578.413 | 480.963 ...

格隆汇8月19日｜英特尔(INTC.US)美股盘后大涨超5%，报24.93美元。软银集团与英特尔签署20亿美元 投资协议，软银将以每股23美元的价格购买英特尔普通股。 ...

Core Viewpoint - In a challenging global consumption environment, Weilong Delicious (09985.HK) reported impressive mid-year results, with total revenue reaching 3.483 billion yuan, an increase of 18.5% year-on-year, and net profit also growing by 18.5% to 736 million yuan [1] Group 1: Financial Performance - For the first half of 2025, the company's total revenue was 3.483 billion yuan, reflecting an 18.5% year-on-year increase [1] - Net profit for the same period reached 736 million yuan, also up 18.5% year-on-year [1] - The company declared an interim dividend of 0.18 yuan per share, with a payout ratio of nearly 60% [2] Group 2: Growth Drivers - Revenue from vegetable products grew by 44.3% year-on-year to 2.109 billion yuan, accounting for 60.5% of total revenue, becoming the core driver of the company's growth [3] - In contrast, revenue from seasoning noodle products decreased by 3.2% to 1.31 billion yuan, representing 37.6% of total revenue [3] - The company is strategically investing in market segments with greater potential, focusing on vegetable products and expanding into seaweed product development [3] Group 3: Channel Strategy - The revenue growth is attributed to enhanced multi-channel and brand building, optimizing channel structure [4] - Online revenue reached 336 million yuan, accounting for 9.6% of total revenue, driven by investments in e-commerce platforms [4] - Offline revenue was approximately 3.147 billion yuan, making up 90.4% of total revenue, with partnerships established with 1,777 offline distributors [4] Group 4: Production Capacity - To meet the growing market demand, the company has increased its production capacity, unveiling its seventh-generation konjac production equipment [5] - The new equipment has doubled production capacity while reducing the footprint and improving quality [5] - The overall expense ratio showed a downward trend, indicating effective cost control and resource allocation [5][6]

Core Viewpoint - KK Group is involved in a legal dispute with Miniso regarding trademark infringement and unfair competition related to its brand "THE COLORIST," which is set to be heard in court on September 1. This case is significant for intellectual property protection in the beauty retail industry [2][4]. Company Overview - KK Group, established in 2015, is a leading new retail enterprise in China, owning multiple brands including "THE COLORIST," "KKV," and X11. The company has expanded to over 1,000 stores across more than 200 cities globally, including locations in Singapore, Thailand, and Malaysia [2][3]. Legal Background - The dispute began in 2019 when KK Group's brand "THE COLORIST" was registered by "Axin Technology" in China and by "Shenzhen Falaisheng" in several overseas countries, both of which are linked to Miniso. KK Group opened its first stores in Guangzhou and Shenzhen on September 26, 2019, quickly gaining recognition as a leading beauty retail brand [3][4]. Previous Legal Actions - Since 2020, KK Group has taken legal actions to protect its trademarks. The Beijing High People's Court ruled in favor of KK Group, stating that the registration by the infringing party constituted "unfair means of registration," leading to the cancellation of the trademark. Additionally, the Nanjing Intermediate People's Court found that Miniso's "WOW COLOUR" store design was highly similar to "THE COLORIST," ordering a cessation of infringement and a compensation of 2 million yuan [4][5]. Industry Context - The beauty retail sector in China has seen explosive growth, with the market size reaching 13 billion yuan in 2021 and projected to exceed 40 billion yuan by 2025. However, the industry faces challenges of homogenization, with many brands adopting similar business models and store designs, making it difficult for consumers to distinguish between them [5][6]. Market Trends - Recent reports indicate a slowdown in growth within the beauty retail sector, with some brands closing stores due to poor management. For instance, Sasa International announced the closure of its last 18 stores in mainland China in June 2025. In the first half of 2025, at least 34 domestic and international brands announced closures or exits from the Chinese market [6].